{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:33:01Z","timestamp":1773149581452,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Cervical cancer burden is still high in low- and middle-income countries, including Botswana. Persistent human papillomavirus (HPV) infection is the leading cause of cervical cancer. Accurate knowledge of HPV diversity associated to cervical cancer in sub-Saharan Africa may provide accurate understanding of the natural history of HPV infection in these contexts. The goal of this review was to consolidate existing evidence on cervical HPV infection and to conduct a pooled analysis of data from all eligible Botswana studies. After a successful review of twelve studies on cervical HPV genotypes that met the inclusion criteria, HPV-16 genotype was the most frequently discovered in women with pre-cancerous and cancer lesions, followed by HPV-18. HPV-16 in HIV-positive women with precancerous lesions to cancer is between 45% and 47.7%, and between 4.5% and 26.1% for HPV-18. With reference to other HPV genotypes, the proportion of HPV-35 and HPV-58 (13-16%) seems relatively consistent among the studies, however HPV-58 appears to be more common in HIV-positive subjects compared to HIV-negative women. Indeed, HPV-45 seems to be frequently detected in women with cervical cancer compared to women with precancerous lesions. Regarding the low-risk HPV genotypes, an appropriate breakdown has been provided. In conclusion, the current prophylactic vaccines against HPV-16 and HPV-18, which have demonstrated good immunogenicity in HIV-infected populations, may still prevent infection and ultimately cancer.<\/jats:p>","DOI":"10.3389\/fmed.2022.1020760","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T04:47:47Z","timestamp":1669265267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana"],"prefix":"10.3389","volume":"9","author":[{"given":"Leabaneng","family":"Tawe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pleasure","family":"Ramatlho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Ketlametswe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Koobotse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erle S.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Ramogola-Masire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo M.","family":"Paganotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"B1","first-page":"4677","article-title":"Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.","volume":"49","author":"Zur Hausen","year":"1989","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1007\/s13277-014-1737-z","article-title":"Epigenetics and cervical cancer: from pathogenesis to therapy.","volume":"35","author":"Fang","year":"2014","journal-title":"Tumour Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:13.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health."},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease.","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ijgo.13879","article-title":"Worldwide initiatives to eliminate cervical cancer.","author":"Wilailak","year":"2021","journal-title":"Int J Gynaecol Obstet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical cancer in low and middle-income countries.","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol Lett."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","article-title":"Cervical cancer control in HIV-infected women: past, present and future.","volume":"21","author":"Ghebre","year":"2017","journal-title":"Gynecol Oncol Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer.","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication.","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijrobp.2018.01.067","article-title":"Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting.","volume":"101","author":"Grover","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135602","article-title":"Cancer incidence following expansion of HIV treatment in Botswana.","volume":"10","author":"Dryden-Peterson","year":"2015","journal-title":"PLoS One."},{"key":"B18","year":"2020","journal-title":"International Agency for Research on Cancer (IARC), Botswana, Globocan 2020."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07130-x","article-title":"HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring.","volume":"22","author":"McClung","year":"2022","journal-title":"BMC Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268822000619","article-title":"Human papillomavirus prevalence in male and female university students in Gaborone, Botswana.","volume":"150","author":"Ramogola-Masire","year":"2022","journal-title":"Epidemiol Infect."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.15585\/mmwr.mm6440a5","article-title":"Human papillomavirus vaccination coverage among school girls in a demonstration project\u2014Botswana, 2013.","volume":"64","author":"Raesima","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B22","author":"Ramogola-Masire","year":"2016","journal-title":"HPV Vaccine for Cervical Cancer Prevention in Botswana."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1016\/j.vaccine.2014.12.002","article-title":"Human papillomavirus vaccines: WHO position paper, October 2014-recommendations.","volume":"33","year":"2015","journal-title":"Vaccine."},{"key":"B24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2471\/BLT.11.097253","article-title":"Achieving high coverage in Rwanda\u2019s national human papillomavirus vaccination programme.","volume":"90","author":"Binagwaho","year":"2012","journal-title":"Bull World Health Organ."},{"key":"B25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7196\/SAMJ.2022.v112i5.16295","article-title":"Human papillomavirus prevalence among unvaccinated young female college students in Botswana: a cross-sectional study.","volume":"112","author":"Ramatlho","year":"2022","journal-title":"S Afr Med J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/PGP.0b013e31821bf2a6","article-title":"Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.","volume":"30","author":"Ramogola-Masire","year":"2011","journal-title":"Int J Gynecol Pathol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0102-9","article-title":"Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications.","volume":"11","author":"Ermel","year":"2016","journal-title":"Infect Agent Cancer."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211260","article-title":"Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay.","volume":"14","author":"Rantshabeng","year":"2019","journal-title":"PLoS One."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/ijc.32581","article-title":"Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.","volume":"146","author":"Tawe","year":"2020","journal-title":"Int J Cancer."},{"key":"B30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcv.2011.08.011","article-title":"Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.","volume":"52","author":"Firnhaber","year":"2011","journal-title":"J Clin Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/jmv.22178","article-title":"Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.","volume":"83","author":"Macleod","year":"2011","journal-title":"J Med Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1177\/0956462419868618","article-title":"Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana.","volume":"30","author":"Elliott","year":"2019","journal-title":"Int J STD AIDS."},{"key":"B33","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/AOG.0000000000003496","article-title":"Performance of two-stage cervical cancer screening with primary high-risk human papillomavirus testing in women living with human immunodeficiency virus.","volume":"134","author":"Luckett","year":"2019","journal-title":"Obstet Gynecol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229086","article-title":"High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.","volume":"15","author":"Castle","year":"2020","journal-title":"PLoS One."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07081-3","article-title":"Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya.","volume":"22","author":"Tawe","year":"2022","journal-title":"BMC Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031103","article-title":"Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana.","volume":"9","author":"Grover","year":"2019","journal-title":"BMJ Open."},{"key":"B37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/QAI.0000000000001113","article-title":"Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa.","volume":"73","author":"Clifford","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257324","article-title":"High-risk HPV genotypes in Zimbabwean women with cervical cancer: comparative analyses between HIV-negative and HIV-positive women.","volume":"16","author":"Kuguyo","year":"2021","journal-title":"PLoS One."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.763717","article-title":"HPV type distribution in HIV Positive and negative women with or without cervical dysplasia or cancer in East Africa.","volume":"11","author":"Mcharo","year":"2021","journal-title":"Front Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/ijc.23292","article-title":"Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.","volume":"122","author":"Castellsagu\u00e9","year":"2008","journal-title":"Int J Cancer."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015653","article-title":"Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique.","volume":"7","author":"Edna Omar","year":"2017","journal-title":"BMJ Open."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/bjc.2012.441","article-title":"Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.","volume":"107","author":"De Vuyst","year":"2012","journal-title":"Br J Cancer."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4102\/sajid.v37i1.363","article-title":"Prevalence and distribution of selected cervical human papillomavirus types in HIV infected and HIV uninfected women in South Africa, 1989\u20132021: a narrative review.","volume":"37","author":"Rikhotso","year":"2022","journal-title":"S Afr J Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women.","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011371","article-title":"Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na\u00efve women: results from the control arm of a phase II HPV-16\/18 vaccine trial.","volume":"6","author":"Ramanakumar","year":"2016","journal-title":"BMJ Open."},{"key":"B47","first-page":"131","article-title":"Roche AMPLICOR human papilloma virus (HPV) and LINEAR ARRAY HPV tests will profit from automated DNA extraction.","volume":"53","author":"Schalasta","year":"2007","journal-title":"Clin Lab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cmi.2017.05.020","article-title":"Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review.","volume":"24","author":"de Thurah","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/ijc.32581","article-title":"Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana","volume":"146","author":"Tawe","year":"2020","journal-title":"Int J Cancer."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1020760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T04:47:51Z","timestamp":1669265271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1020760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":49,"alternative-id":["10.3389\/fmed.2022.1020760"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1020760","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"article-number":"1020760"}}